Authors:
Maliepaard, M
van Gastelen, MA
Tohgo, A
Hausheer, FH
van Waardenburg, RCAM
de Jong, LA
Pluim, D
Beijnen, JH
Schellens, JHM
Citation: M. Maliepaard et al., Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918, CLIN CANC R, 7(4), 2001, pp. 935-941
Authors:
Chaudhuri, AR
Seetharamalu, P
Schwarz, PM
Hausheer, FH
Luduena, RF
Citation: Ar. Chaudhuri et al., The interaction of the B-ring of colchicine with alpha-tubulin: A novel footprinting approach, J MOL BIOL, 303(5), 2000, pp. 679-692
Authors:
Van Hattum, AH
Pinedo, HM
Schluper, HMM
Hausheer, FH
Boven, E
Citation: Ah. Van Hattum et al., New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer, INT J CANC, 88(2), 2000, pp. 260-266
Authors:
Matsui, SI
Endo, W
Wrzosek, C
Haridas, K
Seetharamulu, P
Hausheer, FH
Rustum, YM
Citation: Si. Matsui et al., Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: Mechanisms and clinical implications, EUR J CANC, 35(6), 1999, pp. 984-993
Authors:
Pavankumar, PNV
Seetharamulu, P
Yao, S
Saxe, JD
Reddy, DG
Hausheer, FH
Citation: Pnv. Pavankumar et al., Comprehensive ab initio quantum mechanical and molecular orbital (MO) analysis of cisplatin: Structure, bonding, charge density, and vibrational frequencies, J COMPUT CH, 20(3), 1999, pp. 365-382